Vaishnavi Nivsarkar, PhD
Vaishnavi Nivsarkar, PhD, is a scientific pharma expert and scientific project manager with over five years of experience across pharmaceutical R&D, operations, and strategic program delivery. Her career journey began with a deep interest in research during her school years, which led her to pursue a PhD in Molecular Genetics from the Max Planck Society in Germany. She has since built a strong career in the pharmaceutical industry, currently working at Merck and previously contributing at AstraZeneca and NYU Langone Health. Vaishnavi is recognized for her ability to translate complex scientific programs into data-driven, actionable insights that support both scientific innovation and business strategy.
In her current role at Merck, Vaishnavi focuses on DNA sequencing research, leveraging expertise in Sanger and next-generation sequencing, data analytics, and high-throughput enzyme engineering. Her daily responsibilities include conducting wet-lab experiments, analyzing complex datasets, and supporting drug discovery and development efforts across multiple pipelines. She has led end-to-end sequencing operations for more than ten drug programs, designed SOPs for lab automation and liquid handling systems, and supported product market research and insourcing initiatives. Previously at AstraZeneca, she served as a project lead for companion diagnostic assay development in translational oncology, managing cross-functional teams, vendors, and integrated project plans.
Vaishnavi’s achievements include earning a PhD from a prestigious German research institution, publishing in respected scientific journals, and building experience at top global pharmaceutical companies such as Merck and AstraZeneca. Beyond her professional work, she is an avid traveler who has visited over 15 countries and enjoys exploring well-known tourist destinations across the United States. She also has a creative side, with a passion for digital art that she creates on her iPad, and enjoys unwinding by watching The Big Bang Theory.
• McKinsey.org Forward Program
• ORAQ Regulatory affairs training program
• Project management
• Foundations of Business Strategy
• Max Planck Society - PhD
• Cold Spring Harbour Laboratory Travel Grant
• National Network for Mathematical and Computational Biology (NNMCB), Summer research fellowship
• Indian Academy of Sciences (IAS) summer research fellowship
• DST-INSPIRE fellowship
• CSIR-JRF Ph.D fellowship
• IMPRS Max Planck graduate program
• TIFR JGEEBILS
What advice would you give to young women entering your industry?
I would advise young women entering the industry to be intentional and strategic in their approach. Take targeted steps toward your goals, seek out opportunities that align with where you want to go, and don’t be afraid to ask questions or advocate for yourself. Having a clear sense of direction makes it easier to make informed decisions and build a career with purpose and confidence.
What are the biggest challenges or opportunities in your field right now?
One of the biggest opportunities in my field is the rapid pace of innovation, particularly in AI-based drug discovery and advances in cell and gene therapy. These technologies are transforming how research is conducted, accelerating development timelines, and opening new career pathways across science, data, and technology. Professionals who are willing to adapt and continuously learn are well positioned to grow alongside these advancements.
At the same time, a key challenge is navigating the constant evolution of organizations, departments, and roles as the science advances. As teams and responsibilities shift to keep pace with innovation, it can be difficult to maintain clarity around ownership, collaboration, and long-term career paths. Successfully balancing adaptability with a clear professional focus is essential to thriving in this rapidly changing field.
Locations
Merck
Iselin, NJ 08830